Scarica l'app Stockscreener
5.05
0.40%
0.02
Precedente Chiudi:
$5.03
Aprire:
$5.05
Volume 24 ore:
3,593
Relative Volume:
0.02
Capitalizzazione di mercato:
$55.09M
Reddito:
$2.09M
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-7.5373
EPS:
-0.67
Flusso di cassa netto:
$-3.64M
1 W Prestazione:
+6.99%
1M Prestazione:
-23.14%
6M Prestazione:
-28.87%
1 anno Prestazione:
+18.27%
Intervallo 1D:
$5.02
$5.15
Intervallo di 1 settimana:
$4.5929
$5.20
Portata 52W:
$3.20
$11.78
Nutriband Inc Stock (NTRB) Company Profile
Nome
Nutriband Inc
Settore
Industria
Telefono
407 377-6695
Indirizzo
121 S. ORANGE AVE., ORLANDO
Confronta NTRB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
5.05 | 55.09M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-22 | Iniziato | Noble Capital Markets | Outperform |
Nutriband Inc Borsa (NTRB) Ultime notizie
Nutriband (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Nutriband Advances Opioid Safety with Innovative AVERSA Technology - citybuzz -
Nutriband (NTRB) Achieves Key Patent Approval in Macao for AVERS - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology | NTRB Stock News - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband secures Macao patent for drug abuse deterrent tech By Investing.com - Investing.com South Africa
Nutriband Receives Patent for Abuse, Misuse Deterrent Transdermal Systems in Macao - marketscreener.com
Nutriband secures Macao patent for drug abuse deterrent tech - Investing.com
Revolutionary Opioid Safety Tech: Nutriband Secures 46-Country Patent Protection - Stock Titan
Nutriband Partners with Charlotte FC for Brand Visibility - TipRanks
Nutriband (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility - The Globe and Mail
(NTRB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M - ACCESS Newswire
UPDATENutriband Signs Associate Partnership with Charlotte FC - The Manila Times
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC - Bluefield Daily Telegraph
Nutriband Expands Market Reach: Strategic Partnership With Charlotte FC Spotlights Pain Management Innovation - Stock Titan
Nutriband partners with Charlotte FC to boost brand visibility By Investing.com - Investing.com South Africa
Nutriband Signs Partnership Agreement with Charlotte FC - GlobeNewswire
Nutriband (NTRB) Secures Partnership with Charlotte FC - GuruFocus
Nutriband partners with Charlotte FC to boost brand visibility - Investing.com India
Strategic Alliance: Nutriband Brings Revolutionary Pain Management Tech to Major League Soccer - Stock Titan
Nutriband (NASDAQ:NTRBW) Trading Up 2.6% – Time to Buy? - Defense World
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - ACCESS Newswire
(NTRB) Proactive Strategies - news.stocktradersdaily.com
Critical Analysis: Pathfinder Cell Therapy (OTCMKTS:PFND) and Nutriband (NASDAQ:NTRB) - The AM Reporter
How To Trade (NTRB) - Stock Traders Daily
3 Reasons to Sell UAL and 1 Stock to Buy Instead - The Globe and Mail
Breakeven On The Horizon For Nutriband Inc. (NASDAQ:NTRB) - Simply Wall St
When the Price of (NTRB) Talks, People Listen - Stock Traders Daily
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch - ACCESS Newswire
Nutriband Inc, Orlando - Florida Trend
Nutriband Inc. to Present at the Emerging Growth Conference on May 25 - ACCESS Newswire
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st - ACCESS Newswire
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May - ACCESS Newswire
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4 - ACCESS Newswire
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology - ACCESS Newswire
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - ACCESS Newswire
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M - ACCESS Newswire
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company - ACCESS Newswire
(NTRB) Long Term Investment Analysis - news.stocktradersdaily.com
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary - ACCESS Newswire
Nutriband Receives Certificate of Registration for - GlobeNewswire
Nutriband secures trademark for drug abuse deterrent tech By Investing.com - Investing.com Nigeria
Nutriband secures trademark for drug abuse deterrent tech - Investing.com
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. - The Manila Times
Can This New Trademark Help Nutriband Capture a $200M Drug Delivery Market? - StockTitan
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3 - ACCESS Newswire
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth - MSN
This Surging Pharma Company Could Hit Profitability by 2027 - Elblog.pl
Nutriband Inc Azioni (NTRB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):